about
Recent advances and future prospects in choroideremiaFUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.Bimanual anterior segment revision surgery for anterior capsule contraction syndrome associated with anterior flexion of intraocular lens hapticsMetrics of the normal anterior sclera: imaging with optical coherence tomographyNon-invasive biometric assessment of ocular rigidity in glaucoma patients and controls.In vivo imaging of ocular MCMV infection.Functional and anatomical outcome of eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab following an exit strategy regimen.Investigation of retinal morphology alterations using spectral domain optical coherence tomography in a mouse model of retinal branch and central retinal vein occlusion.Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumabNovelties in Diabetic Retinopathy.Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression.Imaging of macrophage dynamics with optical coherence tomography in anterior ischemic optic neuropathy.Noninvasive Quantification of Retinal Microglia Using Widefield Autofluorescence Imaging.OCT-angiography: A qualitative and quantitative comparison of 4 OCT-A devicesAtypical retinal pigment epithelial defects with retained photoreceptor layers: a so far disregarded finding in age related macular degenerationNext generation sequencing based identification of disease-associated mutations in Swiss patients with retinal dystrophies.Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions.Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular Degeneration.Quantification of retinal layer thickness changes in acute macular neuroretinopathy.T cell responses in experimental viral retinitis: mechanisms, peculiarities and implications for gene therapy with viral vectors.Interferon γ-dependent migration of microglial cells in the retina after systemic cytomegalovirus infection.The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook.Autofluorescence Lifetimes in Patients With Choroideremia Identify Photoreceptors in Areas With Retinal Pigment Epithelium Atrophy.Reply to the Letter by Kaya Entitled 'Fluctuation Speed as a New Criterion to Evaluate the Efficiency of Intravitreal Anti-VEGF Drugs'.Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects.Fluorescence lifetime imaging ophthalmoscopy.Autofluorescence Lifetimes in Geographic Atrophy in Patients With Age-Related Macular Degeneration.Spectral-domain optical coherence tomography findings after severe exogenous endophthalmitis.Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein OcclusionChoroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy.Free tarsal graft combined with skin transposition flap for full-thickness lower eyelid reconstruction.Macular hole surgery in patients with end-stage choroideremia.Microcystic macular edema: retrograde maculopathy caused by optic neuropathy.Acetazolamide influences ocular pulse amplitude.In Vivo Imaging of Cx3cr1gfp/gfp Reporter Mice with Spectral-domain Optical Coherence Tomography and Scanning Laser Ophthalmoscopy.Fluorescence Lifetimes of Drusen in Age-Related Macular Degeneration.Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema.Relationship Between Presumptive Inner Nuclear Layer Thickness and Geographic Atrophy Progression in Age-Related Macular Degeneration.Evaluation of scleral and corneal thickness in keratoconus patients.Saccade testing to distinguish between non-organic and organic visual-field restriction.
P50
Q26773223-CADEA0A9-B9C3-43F7-9074-B66C1D89D2ACQ30490714-EAA3F307-C9E8-4BD5-82C0-8C11A72890C1Q30560258-0F5F1AA5-74BA-4EE1-A933-0033D4C9970AQ30662319-1311C745-B2FF-48D5-B6F5-106BAC959149Q33321773-89C82FBE-8E7B-42A2-90EB-C61CB60740A2Q33493791-A460F373-2ECB-419F-8BF2-4782E31660EFQ34092281-2A84A93A-F790-41D9-8EFE-16CAF68ED111Q35182315-F93EDE0F-D3B1-48E7-8277-142EB6E9EAEDQ35696017-70BBB9BD-91FF-4FE7-BD32-12CA6B87BFF2Q35908271-36C29CF5-D55C-4EF8-B943-9279F2D5C51CQ35942841-7E304E1F-08E5-414D-AD07-1E7760FEBA0EQ36212685-807512F3-C3F8-4AE9-81A8-1C93CBB75245Q36342406-BCFFA8DF-ED3A-4B4B-AFCA-BA3AE0A59823Q36368054-9FE8BF22-690D-441E-875D-4838628441CCQ36372439-4EB8216E-ACD3-419C-8026-B9F2FFA94EF8Q37049729-35711F51-8FFE-42C6-8642-31E912B3F2A7Q37197402-5FE75653-634F-4610-9C70-981845786802Q37588925-5A3732C6-2E1F-44AD-AEB4-1AC4CB9EECBEQ37627224-2F8F1B91-6774-40DD-86E7-B135BF14BDAAQ37873088-536AFB47-D5C6-4D19-BDBC-C3327564A82DQ38318603-97DE3A7A-10B6-4DDD-8A24-120CE5277218Q38669043-6464B7AE-2C9E-4095-AFB6-392B3E7FD43EQ38783941-112A4820-1851-40FC-8D3E-4938122E8423Q38812625-748118DC-D4BE-4AB5-BB3F-1D1CC97338A1Q39244814-14B411FD-3F82-4ABC-9F6D-E8FDA21F9E6CQ39412399-D9438ED7-1420-47C9-97F8-CC96562179A1Q39791359-CB628C1D-DB3B-4B7E-9D06-4FC3F0B0BF97Q41757842-75E7D82B-DF0C-40BD-808C-67AEB70C1EA3Q42035309-5D34F36E-9AA4-4E2D-8784-0320E627FB41Q42411521-E53D4275-7225-443F-8B76-135D0EDCA589Q42513000-628CA374-0D9F-4F12-B70D-E2887D7B2552Q43411722-70E92FEB-92A4-41A5-8B8D-45547E09EB92Q45413688-8F1FC686-EDB0-4FC7-B747-C512511CAA3CQ46089593-F713318C-E09D-46CE-8DD5-06374786DA42Q47384630-82EC7DE2-8D52-45AB-906B-7ED8C60657BFQ47874158-B2E2D413-C98E-44D1-81B3-0791DB2CE8A3Q48316496-FD214938-CA93-4FAA-85BC-EB7D817CF123Q48606450-4805CB8E-BAEB-4518-B119-6DBA4C3B73CDQ50558079-19FCA545-A1AA-4631-8260-7BA2B63C0984Q50606794-CF1010AF-7FB7-4FF3-B592-7FF360451273
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin S Zinkernagel
@nl
Martin S Zinkernagel
@sl
Martin S. Zinkernagel
@en
Martin S. Zinkernagel
@es
type
label
Martin S Zinkernagel
@nl
Martin S Zinkernagel
@sl
Martin S. Zinkernagel
@en
Martin S. Zinkernagel
@es
prefLabel
Martin S Zinkernagel
@nl
Martin S Zinkernagel
@sl
Martin S. Zinkernagel
@en
Martin S. Zinkernagel
@es
P214
P106
P1153
55934334900
P214
P31
P496
0000-0003-3447-2359
P735
P7859
viaf-238560534